- Home
- CSIQ vs TRVI Comparison
CSIQ vs TRVI Comparison
Compare CSIQ & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSIQ | TRVI |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.4B |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CSIQ | TRVI |
|---|---|---|
| Price | $22.86 | $12.83 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $17.63 | ★ $20.59 |
| AVG Volume (30 Days) | ★ 5.5M | 2.4M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,899,139,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.96 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.57 | $3.43 |
| 52 Week High | $34.59 | $14.39 |
Technical Indicators
Market Signals| Indicator | CSIQ | TRVI |
|---|---|---|
| Relative Strength Index (RSI) | 46.94 | 55.32 |
| Support Level | $22.21 | $12.92 |
| Resistance Level | $25.45 | $14.39 |
| Average True Range (ATR) | 2.17 | 0.87 |
| MACD | -0.58 | -0.03 |
| Stochastic Oscillator | 8.55 | 57.94 |
Price Performance
Historical ComparisonAbout CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.